Recombinant Salmonella typhimurium NADH-quinone oxidoreductase subunit A (nuoA)

Why is nuoA significant in bacterial respiratory systems?

NuoA contributes to the proton-pumping function of NDH-1, which is the only proton-pumping NADH dehydrogenase in Salmonella's respiratory chain . Unlike the type II NADH dehydrogenase (encoded by ndh), NDH-1 translocates protons across the membrane to generate a proton motive force, making cells with functional NDH-1 energetically more efficient . This energy conservation is critical for various cellular processes including:

• ATP synthesis via F₁F₀ ATP synthase

• Active transport of nutrients across the cytoplasmic membrane

• Export of unwanted solutes

• Biogenesis and rotation of the flagellum

The significance of nuoA becomes evident in mutational studies where disruptions to the protein affect bacterial motility, growth, and electron transfer capabilities .

What expression systems are most effective for producing recombinant Salmonella nuoA protein?

The optimal expression systems for recombinant nuoA production include:

For recombinant nuoA production, E. coli expression systems are most commonly employed due to the genetic similarity between E. coli and Salmonella typhimurium . When expressing nuoA, researchers typically include a histidine tag to facilitate purification . The recombinant protein is often stored in a Tris-based buffer with 50% glycerol at -20°C for short-term storage or -80°C for extended storage .

How can researchers verify the functionality of recombinant nuoA protein?

Verification of recombinant nuoA functionality requires multiple approaches:

• Enzymatic activity assays: Measuring electron transfer from NADH to various quinones:

  • NADH-oxidase activity assay

  • NADH-DB (dichlorophenolindophenol) reductase assay

  • NADH-K₃Fe(CN)₆ reductase assay

• Membrane incorporation assessment: Confirming proper integration into lipid membranes using:

  • Liposome reconstitution experiments

  • Blue native PAGE for complex formation

  • Immunoblotting with anti-nuoA antibodies

• Complementation studies: Introducing the recombinant protein into nuoA deletion mutants to assess restoration of:

  • Growth defects in minimal media

  • Motility in soft agar

  • Respiratory chain activity

Scientists typically use the inhibitor capsaicin-40 as a control, with IC₅₀ values of 132-151 nM for wild-type NDH-1 activity .

How do mutations in nuoA affect Salmonella pathogenicity and metabolism?

Mutations in nuoA have profound effects on Salmonella typhimurium pathogenicity and metabolism:

Research demonstrates that nuoA disruption affects the ability of Salmonella to adapt to different environmental conditions, potentially influencing infection dynamics .

What is known about the structural interactions between nuoA and other subunits of the NDH-1 complex?

The structural interactions between nuoA and other NDH-1 subunits are complex and critical for enzyme function:

• Membrane domain associations: NuoA interacts closely with other membrane-embedded subunits, particularly NuoH, NuoJ, NuoK, NuoM, and NuoN to form proton translocation channels .

• Interaction with peripheral domain: Though primarily membrane-embedded, nuoA also forms contacts with the hydrophilic domain containing subunits like NuoG .

• Quinone binding pocket contribution: While nuoA itself does not directly form the quinone binding site, mutations in adjacent subunits (like nuoG, nuoM, and nuoN) can affect quinone interactions and electron transfer efficiency .

Recent research employing suppressor mutations has revealed unexpected connections between nuoA function and other subunits. For example, when ubiquinone biosynthesis is disrupted, specific mutations in nuoG (Q297K), nuoM (A254S), and nuoN (A444E) can partially rescue electron flow through NDH-1, suggesting complex allosteric interactions between these subunits and nuoA within the respiratory complex .

How does the electron transfer mechanism involving nuoA function under different respiratory conditions?

The electron transfer mechanism involving nuoA varies significantly under different respiratory conditions:

Under aerobic conditions, nuoA participates in the NDH-1 complex to facilitate electron transfer from NADH ultimately to ubiquinone, which serves as the primary electron acceptor . In contrast, under anaerobic conditions, Salmonella shifts toward using demethylmenaquinone and menaquinone as alternative electron carriers .

This flexibility allows Salmonella to adjust its respiratory chain according to available electron acceptors. Interestingly, research with ubiquinone biosynthesis mutants (ΔubiA or ΔubiE) has shown that NDH-1 containing nuoA can adapt to utilize alternative quinones, though with reduced efficiency . This adaptation is crucial for Salmonella's ability to survive in diverse host environments during infection .

What techniques are most effective for studying nuoA mutations and their phenotypic effects?

Several complementary techniques have proven effective for studying nuoA mutations:

• Gene deletion and complementation:

  • Construction of precise nuoA deletion mutants using λ-Red recombination

  • Complementation with plasmid-expressed wild-type or mutant nuoA

  • Phenotypic analysis of swimming motility in soft tryptone agar

• Suppressor mutation screening:

  • Selection of spontaneous suppressor mutants that rescue growth/motility defects

  • Whole-genome sequencing to identify compensatory mutations

  • Site-directed mutagenesis to confirm causative mutations

• Biochemical characterization:

  • Membrane preparation and enzyme activity assays

  • Analysis of quinone composition by reversed-phase HPLC

  • Immunoblotting to quantify protein expression levels

A particularly valuable approach combines these methods: researchers first construct a nuoA deletion, then screen for suppressor mutations, identify them through sequencing, and finally confirm their effects through biochemical characterization .

How can researchers utilize recombinant nuoA in vaccine development research?

Recombinant nuoA has potential applications in vaccine development research through several approaches:

• Live attenuated Salmonella vaccine vectors:

  • Modification of nuoA to create attenuated Salmonella strains

  • Use of attenuated strains expressing nuoA as part of multivalent vaccines

  • Evaluation of immune responses to nuoA-containing constructs

• Subunit vaccine development:

  • Purified recombinant nuoA as a potential antigenic target

  • Analysis of immunogenicity and protective capacity

  • Combination with other Salmonella antigens for enhanced protection

• Adjuvant research:

  • Investigation of nuoA's potential as an immune-stimulating component

  • Evaluation of its ability to enhance responses to other antigens

  • Comparison with other bacterial proteins for adjuvant properties

Researchers have shown that attenuated Salmonella strains can serve as effective vaccine vectors for delivering passenger antigens to mucosal sites, inducing humoral, cellular, and mucosal immunity . The proper functioning of the respiratory chain, which includes nuoA, is critical for the optimal performance of these vaccine vectors .

What regulatory considerations apply to research involving recombinant Salmonella nuoA?

Research involving recombinant Salmonella nuoA must adhere to several regulatory frameworks:

• NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules:

  • Most recombinant work with Salmonella falls under Sections III-D, III-E, or III-F

  • Requires Institutional Biosafety Committee (IBC) approval prior to initiation

  • Specific containment requirements based on risk assessment

• Biosafety considerations:

  • Salmonella typhimurium is typically classified as a Risk Group 2 organism

  • Work requires at minimum Biosafety Level 2 (BSL-2) facilities and practices

  • Additional containment may be needed for certain recombinant constructs

• Documentation requirements:

  • Detailed research proposal submission to IBC

  • Documentation of safety procedures and containment measures

  • Regular reporting and updates for ongoing work

For experiments involving the alteration of virulence traits or introduction of foreign genes into Salmonella, researchers must adhere to Section III-D-1 of the NIH Guidelines, which requires IBC approval before initiating experiments . This regulatory oversight ensures the safe conduct of research while promoting scientific advancement.

How does nuoA research contribute to understanding bacterial resistance to antimicrobials?

Research on nuoA contributes to understanding antimicrobial resistance through several mechanisms:

• Energy metabolism and antibiotic tolerance:

  • NDH-1 function affects bacterial persistence during antibiotic exposure

  • Altered respiratory chain activity can influence susceptibility to certain antibiotics

  • NuoA mutations can affect proton motive force-dependent drug efflux systems

• Metabolic adaptation during infection:

  • Understanding how nuoA contributes to Salmonella's adaptation to host environments

  • Identification of potential metabolic vulnerabilities that could be targeted

  • Analysis of respiratory chain function under iron-restricted conditions

• Novel antimicrobial targets:

  • The structure and function of nuoA present potential drug targets

  • Inhibition of NDH-1 function could impair Salmonella growth and virulence

  • Compounds targeting nuoA interactions might synergize with existing antibiotics

Recent research has shown that the NDH-1 complex is particularly important for Salmonella to cope with iron-restricted conditions during infection, with the complementary NDH-2 (encoded by ndh) being required for adaptation to these conditions . This understanding could lead to novel therapeutic approaches targeting bacterial respiratory chains.

What are the current technical challenges in studying nuoA structure-function relationships?

Researchers face several technical challenges when investigating nuoA structure-function relationships:

Current approaches to address these challenges include using suppressor mutations to identify functional interactions between subunits, as demonstrated in studies where mutations in nuoG, nuoM, or nuoN partially rescued function in ubiquinone biosynthesis mutants . Additionally, researchers are employing comparative genome sequence analysis to identify evolutionarily conserved residues that may be critical for nuoA function .